Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07456488

The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Liaquat National Hospital & Medical College · Academic / Other
Sex
All
Age
4 Years – 16 Years
Healthy volunteers
Not accepted

Summary

In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction

Conditions

Interventions

TypeNameDescription
DRUGAtropine 0.01% eye dropsEye drops atropine 0.01% given once nightly to group A for 6 months

Timeline

Start date
2025-07-13
Primary completion
2026-04-17
Completion
2026-04-30
First posted
2026-03-06
Last updated
2026-03-06

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07456488. Inclusion in this directory is not an endorsement.